Glenmark gets FDA OK for generic Zytiga

Glenmark has received the Food and Drug Administration’s blessing for abiraterone acetate tablets in a dosage strength of 250 mg.

The product is a generic version of Janssen Biotech’s Zytiga tablets, 250 mg.         

Zytiga tablets, 250 mg had a market value of $794.1 million for the 12 month period ended August 2019, according to IQVIA.